000			04172nam a22003255i 4500
999			_c403033 _d403033
001			403033
003			ES-MaUEC
005			20240711100122.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			240228s2023 si | o |||| 0|eng d
020			_a9789819968077
024	7		_a10.1007/978-981-99-6807-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRS199.5 _b2023 EB
245	0	0	_aDrug Delivery Strategies in Neurological Disorders : _bChallenges and Opportunities _cedited by Awanish Mishra, Hitesh Kulhari
250			_a1st ed. 2023
264		1	_aSingapore _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aSection A: Anatomy and Physiology of Human Nervous System -- Chapter 1. Nanocarriers as an emerging tool for drug delivery to combat neurodegenerative diseases -- Chapter 2. Challenges in drug development for neurological disorders -- Chapter 3. Transporter systems and metabolism at the blood-brain barrier and blood-CSF barrier -- Section B: Pathophysiology and management of Neurological disorders -- Chapter 4. Pathophysiology and management approaches for Alzheimer's Disease -- Chapter 5. Pathophysiology and management approaches for Parkinson's Disease -- Chapter 6 Pathophysiology and management approaches for Epilepsy -- Chapter 7. Pathophysiology and management approaches for Epilepsy -- Chapter 8. Pathophysiology and management approaches for Multiple Sclerosis, Huntington's disease, and other neurodegenerative diseases -- Chapter 9. Genes Encoding Ion Channels in Neurotherapeutics: Opportunities and Challenges -- Chapter 10. Herbal approaches for the management of neurological disorders -- Section C: Drug Delivery Strategies in Neurological disorders -- Chapter 11. Essential Considerations for brain delivery of nanoformulations -- Chapter 12. Drug delivery strategies in Alzheimer's disease -- Chapter 13. Drug delivery strategies in Parkinson's disease -- Chapter 14. Drug delivery strategies in Epilepsy -- Chapter 15. Drug delivery strategies in Traumatic Brain Injury -- Chapter 16. Drug delivery strategies in Multiple Sclerosis, Huntington's disease, and other neurodegenerative diseases -- Chapter 17. Nose-to-brain strategies for neurological disorders -- Chapter 18. Drug delivery strategies for the delivery of natural compounds to the brain.
520			_aThis book comprehensively reviews the recent progress in the pathogenesis and management approaches for neurological disorders. It focuses on understanding the molecular mechanism, pathology, and novel nanotechnology-based approaches against stroke, Alzheimer's disease, Parkinson's disease, Huntington's disease, Multiple sclerosis, and Epilepsy. The book provides a basic understanding of the development and progression of these diseases, and recent pharmacotherapeutic approaches for their management. It also discusses challenges in drug development for neurological disorders, including preclinical models of disorders, the need for drugs to cross the blood-brain barrier, and a limited understanding of relevant pathophysiology. The book also focuses on different conventional and novel strategies for drug delivery in neurological disorders. Towards the end, the book reviews the applications of nanotechnology for the diagnosis of neurological disorders. One of the chapters is focused on the role of herbal actives in the treatment of neurological disorders. Finally, a chapter is included on nanotechnology-based approaches for the diagnosis of neurological disorders. This book is a useful resource for students and researchers of pharmaceutical sciences, life sciences, material sciences, and nano sciences.
988			_aSpringer_Medicine_2023
650		7	_2embne _9137893 _aFarmacología
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-6807-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b07/2024 _dz _eu _zSI